Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of May 4, 2026: market cap $6.1B; returns 1 week +0.0%, 1 year +1412.9%.

Terns Pharmaceuticals, Inc. (TERN) is a clinical-stage biopharmaceutical company focused on developing small-molecule product candidates for the treatment of oncology and obesity. As a pre-revenue biotech, the company generates no significant revenue from product sales, relying instead on cash reserves from equity financings and partnerships to fund R&D operations.

TERN financial model: income statement, cash flow and balance sheet